<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00221832</url>
  </required_header>
  <id_info>
    <org_study_id>0261.5</org_study_id>
    <nct_id>NCT00221832</nct_id>
  </id_info>
  <brief_title>Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases</brief_title>
  <official_title>Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is the identification of familial congenital arrhythmogenic disorders
      and their clinical follow-up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Molecular genetic screening in patients with:

        -  supraventricular

        -  ventricular arrhythmia

        -  syncopes of unknown origin and/or suspicion of an arrhythmogenic origin

        -  family members of patients with sudden cardiac death and aborted sudden cardiac death

      Examination of patients includes routine testing like electrocardiogram (ECG), sequential
      ECGs, exercise testing, invasive electrophysiological stimulation, cardiac magnetic resonance
      imaging, intravenous drug challenge for identification/exclusion of eg Brugada syndrome.
      Examples are patients with Long QT Syndrome, Short QT Syndrome, Brugada Syndrome, familial
      atrial fibrillation, WPW-syndrome, arrhythmias due to familial hypertrophic cardiomyopathy or
      arrhythmogenic right ventricular dysplasia. Blood samples are taken for further molecular
      genetic screening.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2003</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Long QT Syndrome</condition>
  <condition>Hypertrophic Cardiomyopathy</condition>
  <condition>Arrhythmogenic Right Ventricular Dysplasia</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      no biospecimens are to be retained.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patient sampling with history of syncope, aborted SCD, familial sudden cardiac
        death, high suspicion of familial cardiac arrhythmias.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a history of syncope, abnormal ECG and suspicion of an arrhythmogenic
             disease

          -  Patients with long QT syndrome

          -  Patients with short QT syndrome, shortened QT intervals, borderline shortened QT
             intervals

          -  Patients with Brugada syndrome

          -  Patients with hypertrophic cardiomyopathy

          -  Patients with arrhythmogenic right ventricular dysplasia

        Exclusion Criteria:

          -  Inability to understand study protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Borggrefe, Prof., MD</last_name>
    <role>Study Director</role>
    <affiliation>I. Department of Medicine-Cardiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian Wolpert, MD</last_name>
    <phone>+49-621-383-2206</phone>
    <email>christian.wolpert@med.ma.uni-heidelberg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rainer Schimpf, MD</last_name>
    <phone>+49-621-383-2206</phone>
    <email>rainer.schimpf@med.ma.uni-heidelberg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Mannheim, I. Department of Medicine</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Wolpert, MD</last_name>
      <phone>+49-621-3832206</phone>
      <email>christian.wolpert@med.ma.uni-heidelberg.de</email>
    </contact>
    <contact_backup>
      <last_name>Rainer Schimpf, MD</last_name>
      <phone>+49-621-3832206</phone>
      <email>rainer.schimpf@med.ma.uni-heidelberg.de</email>
    </contact_backup>
    <investigator>
      <last_name>Christian Wolpert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2003</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2005</study_first_submitted>
  <study_first_submitted_qc>September 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>January 12, 2010</last_update_submitted>
  <last_update_submitted_qc>January 12, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 13, 2010</last_update_posted>
  <responsible_party>
    <name_title>Prof. C. Wolpert, I. Department of Medicine-Cardiology, University Hospital Mannheim</name_title>
    <organization>. Department of Medicine-Cardiology, University Hospital Mannheim</organization>
  </responsible_party>
  <keyword>Long QT Syndrome</keyword>
  <keyword>Hypertrophic cardiomyopathy</keyword>
  <keyword>arrhythmogenic right ventricular dysplasia</keyword>
  <keyword>Short QT Syndrome</keyword>
  <keyword>Brugada Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
    <mesh_term>Cardiomyopathy, Hypertrophic</mesh_term>
    <mesh_term>Long QT Syndrome</mesh_term>
    <mesh_term>Arrhythmogenic Right Ventricular Dysplasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

